
2seventy bio, Inc. - Common Stock
Share · US9013841070 · TSVT (XNAS)
5,00 USD
12.05.2025 19:59
Current Prices from 2seventy bio, Inc. - Common Stock
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
TSVT
|
USD
|
12.05.2025 19:59
|
5,00 USD
| 5,00 USD |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 0,00 % | 0,00 % | 79,86 % | 41,64 % | 21,07 % | -63,69 % |
Company Profile for 2seventy bio, Inc. - Common Stock Share
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Company Data
Name 2seventy bio, Inc. - Common Stock
Company 2seventy bio, Inc.
Symbol TSVT
Website
https://www.2seventybio.com
Primary Exchange
NASDAQ

ISIN US9013841070
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. William D. Baird III, M.B.A.
Market Capitalization 261 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 60 Binney Street, 02142 Cambridge
IPO Date 2021-11-03
ID Changes
Date | From | To |
---|---|---|
05.11.2021 | TSVTV | TSVT |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | TSVT |
More Shares
Investors who 2seventy bio, Inc. - Common Stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.